

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | proteasome assembly (GO:0043248) | 5.43766936 |
| 2 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.06167935 |
| 3 | axon ensheathment in central nervous system (GO:0032291) | 4.86924409 |
| 4 | central nervous system myelination (GO:0022010) | 4.86924409 |
| 5 | fatty acid elongation (GO:0030497) | 4.65414256 |
| 6 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.63942092 |
| 7 | protein maturation by protein folding (GO:0022417) | 4.59085132 |
| 8 | presynaptic membrane organization (GO:0097090) | 4.57248240 |
| 9 | ATP synthesis coupled proton transport (GO:0015986) | 4.45555387 |
| 10 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.45555387 |
| 11 | protein neddylation (GO:0045116) | 4.28043172 |
| 12 | presynaptic membrane assembly (GO:0097105) | 4.25119020 |
| 13 | chaperone-mediated protein transport (GO:0072321) | 4.21278611 |
| 14 | respiratory electron transport chain (GO:0022904) | 4.16181544 |
| 15 | electron transport chain (GO:0022900) | 4.06177327 |
| 16 | signal peptide processing (GO:0006465) | 4.03184819 |
| 17 | regulation of integrin-mediated signaling pathway (GO:2001044) | 4.03083097 |
| 18 | protein complex biogenesis (GO:0070271) | 4.01148249 |
| 19 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.89402056 |
| 20 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.88666746 |
| 21 | platelet dense granule organization (GO:0060155) | 3.81688728 |
| 22 | negative regulation of ligase activity (GO:0051352) | 3.73488165 |
| 23 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.73488165 |
| 24 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.70441945 |
| 25 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.70441945 |
| 26 | NADH dehydrogenase complex assembly (GO:0010257) | 3.70441945 |
| 27 | mannosylation (GO:0097502) | 3.67124726 |
| 28 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.64539223 |
| 29 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.61537169 |
| 30 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.54713465 |
| 31 | nucleotide transmembrane transport (GO:1901679) | 3.50283411 |
| 32 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.50230281 |
| 33 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.47542277 |
| 34 | respiratory chain complex IV assembly (GO:0008535) | 3.35777211 |
| 35 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.28264301 |
| 36 | cullin deneddylation (GO:0010388) | 3.27133298 |
| 37 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.21449463 |
| 38 | protein deneddylation (GO:0000338) | 3.20683559 |
| 39 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.14941655 |
| 40 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.13058088 |
| 41 | viral protein processing (GO:0019082) | 3.11034020 |
| 42 | cell adhesion mediated by integrin (GO:0033627) | 3.08891246 |
| 43 | cytochrome complex assembly (GO:0017004) | 3.03902095 |
| 44 | extracellular fibril organization (GO:0043206) | 3.03496622 |
| 45 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.01860152 |
| 46 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.01825519 |
| 47 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.01825519 |
| 48 | hydrogen ion transmembrane transport (GO:1902600) | 3.01453341 |
| 49 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.00199218 |
| 50 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.00199218 |
| 51 | negative regulation of neurotransmitter transport (GO:0051589) | 2.99537240 |
| 52 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.97830700 |
| 53 | regulation of cellular amine metabolic process (GO:0033238) | 2.97760212 |
| 54 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.97571385 |
| 55 | polyamine biosynthetic process (GO:0006596) | 2.96884380 |
| 56 | de novo protein folding (GO:0006458) | 2.96735648 |
| 57 | endothelium development (GO:0003158) | 2.96702132 |
| 58 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.96310679 |
| 59 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.96310679 |
| 60 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.96310679 |
| 61 | cyclooxygenase pathway (GO:0019371) | 2.93230127 |
| 62 | aldehyde catabolic process (GO:0046185) | 2.90281275 |
| 63 | response to redox state (GO:0051775) | 2.89919598 |
| 64 | phagosome maturation (GO:0090382) | 2.89240224 |
| 65 | positive regulation of ligase activity (GO:0051351) | 2.88950487 |
| 66 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.88906083 |
| 67 | proton transport (GO:0015992) | 2.88068173 |
| 68 | ribosome assembly (GO:0042255) | 2.85758700 |
| 69 | hydrogen transport (GO:0006818) | 2.83513762 |
| 70 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.83443849 |
| 71 | substantia nigra development (GO:0021762) | 2.82803188 |
| 72 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.81925171 |
| 73 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.81925171 |
| 74 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.81174552 |
| 75 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.80703276 |
| 76 | transferrin transport (GO:0033572) | 2.77835543 |
| 77 | neuron cell-cell adhesion (GO:0007158) | 2.75527401 |
| 78 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.74508978 |
| 79 | cellular response to arsenic-containing substance (GO:0071243) | 2.74453791 |
| 80 | cholesterol biosynthetic process (GO:0006695) | 2.73505341 |
| 81 | GPI anchor biosynthetic process (GO:0006506) | 2.73110016 |
| 82 | establishment of integrated proviral latency (GO:0075713) | 2.72718433 |
| 83 | oligodendrocyte differentiation (GO:0048709) | 2.72604515 |
| 84 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.70727769 |
| 85 | L-phenylalanine catabolic process (GO:0006559) | 2.70727769 |
| 86 | regulation of ligase activity (GO:0051340) | 2.70712667 |
| 87 | COPI coating of Golgi vesicle (GO:0048205) | 2.69966625 |
| 88 | Golgi transport vesicle coating (GO:0048200) | 2.69966625 |
| 89 | regulation of autophagic vacuole assembly (GO:2000785) | 2.68261316 |
| 90 | fibril organization (GO:0097435) | 2.66413959 |
| 91 | de novo posttranslational protein folding (GO:0051084) | 2.66117016 |
| 92 | glutathione biosynthetic process (GO:0006750) | 2.63541622 |
| 93 | cell redox homeostasis (GO:0045454) | 2.63424497 |
| 94 | thrombin receptor signaling pathway (GO:0070493) | 2.63310574 |
| 95 | myelination (GO:0042552) | 2.59949889 |
| 96 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.59854863 |
| 97 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.59854863 |
| 98 | establishment of viral latency (GO:0019043) | 2.59592485 |
| 99 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.59369631 |
| 100 | amyloid precursor protein catabolic process (GO:0042987) | 2.58937127 |
| 101 | ferric iron transport (GO:0015682) | 2.57259169 |
| 102 | trivalent inorganic cation transport (GO:0072512) | 2.57259169 |
| 103 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.56485439 |
| 104 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.55559379 |
| 105 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.55247233 |
| 106 | DNA double-strand break processing (GO:0000729) | 2.55160224 |
| 107 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.55071356 |
| 108 | negative regulation of protein ubiquitination (GO:0031397) | 2.54630534 |
| 109 | GPI anchor metabolic process (GO:0006505) | 2.54414319 |
| 110 | ensheathment of neurons (GO:0007272) | 2.53504054 |
| 111 | axon ensheathment (GO:0008366) | 2.53504054 |
| 112 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.53359164 |
| 113 | negative regulation of platelet activation (GO:0010544) | 2.52682167 |
| 114 | amyloid precursor protein metabolic process (GO:0042982) | 2.48764767 |
| 115 | membrane assembly (GO:0071709) | 2.48061198 |
| 116 | sterol biosynthetic process (GO:0016126) | 2.47141509 |
| 117 | pH reduction (GO:0045851) | 2.46982903 |
| 118 | glycerophospholipid catabolic process (GO:0046475) | 2.46930118 |
| 119 | magnesium ion transport (GO:0015693) | 2.46328448 |
| 120 | polyamine metabolic process (GO:0006595) | 2.43705408 |
| 121 | ATP biosynthetic process (GO:0006754) | 2.43289098 |
| 122 | protein targeting to mitochondrion (GO:0006626) | 2.41305841 |
| 123 | negative regulation of mitochondrion organization (GO:0010823) | 2.41267662 |
| 124 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.41101668 |
| 125 | termination of RNA polymerase III transcription (GO:0006386) | 2.41101668 |
| 126 | regulation of mononuclear cell migration (GO:0071675) | 2.41039925 |
| 127 | lipopolysaccharide metabolic process (GO:0008653) | 2.40701786 |
| 128 | copper ion homeostasis (GO:0055070) | 2.39810803 |
| 129 | very long-chain fatty acid metabolic process (GO:0000038) | 2.39547100 |
| 130 | positive regulation of mitochondrial fission (GO:0090141) | 2.39536809 |
| 131 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.39372483 |
| 132 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.39229566 |
| 133 | isoprenoid biosynthetic process (GO:0008299) | 2.38730213 |
| 134 | regulation of catecholamine metabolic process (GO:0042069) | 2.38604801 |
| 135 | regulation of dopamine metabolic process (GO:0042053) | 2.38604801 |
| 136 | regulation of protein targeting to membrane (GO:0090313) | 2.38429561 |
| 137 | cellular copper ion homeostasis (GO:0006878) | 2.38202657 |
| 138 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.37618679 |
| 139 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.37618679 |
| 140 | regulation of fever generation (GO:0031620) | 2.37181863 |
| 141 | negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 2.37147146 |
| 142 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.37010476 |
| 143 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.36680887 |
| 144 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.35685838 |
| 145 | protein localization to mitochondrion (GO:0070585) | 2.35568103 |
| 146 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.34085787 |
| 147 | glutathione derivative biosynthetic process (GO:1901687) | 2.34081994 |
| 148 | glutathione derivative metabolic process (GO:1901685) | 2.34081994 |
| 149 | mitotic nuclear envelope reassembly (GO:0007084) | 2.33932407 |
| 150 | nuclear envelope reassembly (GO:0031468) | 2.33932407 |
| 151 | intracellular pH reduction (GO:0051452) | 2.33283975 |
| 152 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.33272781 |
| 153 | L-methionine salvage (GO:0071267) | 2.33262204 |
| 154 | L-methionine biosynthetic process (GO:0071265) | 2.33262204 |
| 155 | amino acid salvage (GO:0043102) | 2.33262204 |
| 156 | L-phenylalanine metabolic process (GO:0006558) | 2.33134670 |
| 157 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.33134670 |
| 158 | regulation of collateral sprouting (GO:0048670) | 2.32888058 |
| 159 | membrane lipid catabolic process (GO:0046466) | 2.32451612 |
| 160 | mitotic metaphase plate congression (GO:0007080) | 2.32451479 |
| 161 | negative regulation of JAK-STAT cascade (GO:0046426) | 2.32182024 |
| 162 | keratan sulfate catabolic process (GO:0042340) | 2.31550418 |
| 163 | peroxisome fission (GO:0016559) | 2.31459410 |
| 164 | sequestering of actin monomers (GO:0042989) | 2.31343366 |
| 165 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.31132597 |
| 166 | dopamine biosynthetic process (GO:0042416) | 2.30613259 |
| 167 | platelet degranulation (GO:0002576) | 2.29132180 |
| 168 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.28593253 |
| 169 | limb bud formation (GO:0060174) | 2.26229946 |
| 170 | nucleoside diphosphate catabolic process (GO:0009134) | 2.26092507 |
| 171 | positive regulation of amino acid transport (GO:0051957) | 2.25872152 |
| 172 | GTP biosynthetic process (GO:0006183) | 2.25021207 |
| 173 | regulation of vacuole organization (GO:0044088) | 2.25020358 |
| 174 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.24503749 |
| 175 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.24493181 |
| 176 | regulation of metalloenzyme activity (GO:0048552) | 2.24300525 |
| 177 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.23996710 |
| 178 | virion attachment to host cell (GO:0019062) | 2.21919236 |
| 179 | adhesion of symbiont to host cell (GO:0044650) | 2.21919236 |
| 180 | cofactor catabolic process (GO:0051187) | 2.21365147 |
| 181 | neutrophil activation involved in immune response (GO:0002283) | 2.21115365 |
| 182 | response to misfolded protein (GO:0051788) | 2.20926182 |
| 183 | negative regulation of protein localization to cell surface (GO:2000009) | 2.20129945 |
| 184 | neural nucleus development (GO:0048857) | 2.19692449 |
| 185 | positive regulation of protein homodimerization activity (GO:0090073) | 2.17924421 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.43798466 |
| 2 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.98167041 |
| 3 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.91784091 |
| 4 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.68139324 |
| 5 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.65254955 |
| 6 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.44618461 |
| 7 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.30836802 |
| 8 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.27855345 |
| 9 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.24333220 |
| 10 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.23545599 |
| 11 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.18157592 |
| 12 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.14570642 |
| 13 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.14295354 |
| 14 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.14272913 |
| 15 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.12132493 |
| 16 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.10114848 |
| 17 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.09354797 |
| 18 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.07134311 |
| 19 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.01716831 |
| 20 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.01596512 |
| 21 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.00531849 |
| 22 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.96604420 |
| 23 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.94196990 |
| 24 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.93593373 |
| 25 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.90256674 |
| 26 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.89230398 |
| 27 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.88784562 |
| 28 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.87659363 |
| 29 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.87564762 |
| 30 | VDR_22108803_ChIP-Seq_LS180_Human | 1.85324715 |
| 31 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.82693386 |
| 32 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.82103751 |
| 33 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.80780073 |
| 34 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.74932003 |
| 35 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.74794061 |
| 36 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.73967621 |
| 37 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.72543335 |
| 38 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.70597846 |
| 39 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.67863684 |
| 40 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.65501586 |
| 41 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.65367142 |
| 42 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.64187239 |
| 43 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.62733941 |
| 44 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.61835882 |
| 45 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.61234485 |
| 46 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.60489851 |
| 47 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.60437945 |
| 48 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.60045021 |
| 49 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.59949769 |
| 50 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.58745151 |
| 51 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.58423443 |
| 52 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.57705325 |
| 53 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.56427532 |
| 54 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.56325475 |
| 55 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.56323405 |
| 56 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.55328131 |
| 57 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.53189416 |
| 58 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.49079486 |
| 59 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.47218182 |
| 60 | P300_19829295_ChIP-Seq_ESCs_Human | 1.46322802 |
| 61 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.45619059 |
| 62 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.45415249 |
| 63 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.45415249 |
| 64 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.45005374 |
| 65 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.43726919 |
| 66 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.43182804 |
| 67 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.40945967 |
| 68 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.39687337 |
| 69 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.39002485 |
| 70 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.37859032 |
| 71 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.34473981 |
| 72 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.34074821 |
| 73 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.33498342 |
| 74 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.33296896 |
| 75 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.32899656 |
| 76 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.29193163 |
| 77 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.27662802 |
| 78 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.26657598 |
| 79 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.24598420 |
| 80 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.23660686 |
| 81 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.23533841 |
| 82 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.23464559 |
| 83 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.23017932 |
| 84 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.22817709 |
| 85 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.22471806 |
| 86 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.22440124 |
| 87 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.22393260 |
| 88 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.22069246 |
| 89 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.21826337 |
| 90 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.21591876 |
| 91 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.19534993 |
| 92 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.19033911 |
| 93 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.19033911 |
| 94 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.18788711 |
| 95 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.18134755 |
| 96 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.18003859 |
| 97 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.17203343 |
| 98 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.17073493 |
| 99 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.17021234 |
| 100 | EWS_26573619_Chip-Seq_HEK293_Human | 1.16675230 |
| 101 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.14904431 |
| 102 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.13650913 |
| 103 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.13554146 |
| 104 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.13554146 |
| 105 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.13510033 |
| 106 | CJUN_26792858_Chip-Seq_BT549_Human | 1.12981935 |
| 107 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.12697719 |
| 108 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.12674325 |
| 109 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.12279251 |
| 110 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.11498591 |
| 111 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.10681567 |
| 112 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.10361318 |
| 113 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.08834230 |
| 114 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.07997121 |
| 115 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.06518542 |
| 116 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.06282548 |
| 117 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.05419128 |
| 118 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.05020001 |
| 119 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.04746796 |
| 120 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.04663335 |
| 121 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.04217152 |
| 122 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.03512202 |
| 123 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.02085337 |
| 124 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.01954702 |
| 125 | * NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.00606893 |
| 126 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.00401594 |
| 127 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.00309262 |
| 128 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.99469504 |
| 129 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.99255216 |
| 130 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99238700 |
| 131 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.99036401 |
| 132 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.98899623 |
| 133 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.98825315 |
| 134 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.98587347 |
| 135 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.98123894 |
| 136 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.97982692 |
| 137 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.97683739 |
| 138 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97009608 |
| 139 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.96977677 |
| 140 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.96785018 |
| 141 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.95745367 |
| 142 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.94053246 |
| 143 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.93668329 |
| 144 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.92899137 |
| 145 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.92056338 |
| 146 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.91935508 |
| 147 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.91847951 |
| 148 | FUS_26573619_Chip-Seq_HEK293_Human | 0.91684122 |
| 149 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.91421356 |
| 150 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.91108178 |
| 151 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.90683646 |
| 152 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90157423 |
| 153 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.90052146 |
| 154 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.88716293 |
| 155 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.88671638 |
| 156 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.88549896 |
| 157 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.88509475 |
| 158 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.88486883 |
| 159 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.88481081 |
| 160 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.86082479 |
| 161 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.85589307 |
| 162 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.85564607 |
| 163 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.85449245 |
| 164 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.84582316 |
| 165 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.84207185 |
| 166 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.84118275 |
| 167 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.83983753 |
| 168 | * PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.83548298 |
| 169 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.83133240 |
| 170 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.83094721 |
| 171 | JUN_21703547_ChIP-Seq_K562_Human | 0.83073554 |
| 172 | KDM2B_26808549_Chip-Seq_REH_Human | 0.82758674 |
| 173 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.82542908 |
| 174 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.82017973 |
| 175 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.81868992 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0006054_spinal_hemorrhage | 3.75307664 |
| 2 | MP0003880_abnormal_central_pattern | 3.23471811 |
| 3 | MP0004272_abnormal_basement_membrane | 3.20489851 |
| 4 | MP0003941_abnormal_skin_development | 3.14471224 |
| 5 | MP0005464_abnormal_platelet_physiology | 2.97550677 |
| 6 | MP0001529_abnormal_vocalization | 2.75994979 |
| 7 | MP0009840_abnormal_foam_cell | 2.66026968 |
| 8 | MP0000920_abnormal_myelination | 2.65377058 |
| 9 | MP0002254_reproductive_system_inflammat | 2.61968071 |
| 10 | MP0001905_abnormal_dopamine_level | 2.61621461 |
| 11 | MP0000343_altered_response_to | 2.61589295 |
| 12 | MP0005171_absent_coat_pigmentation | 2.38706774 |
| 13 | MP0004043_abnormal_pH_regulation | 2.37096995 |
| 14 | MP0010386_abnormal_urinary_bladder | 2.18703322 |
| 15 | MP0003195_calcinosis | 2.10719347 |
| 16 | MP0009379_abnormal_foot_pigmentation | 2.04900154 |
| 17 | MP0006276_abnormal_autonomic_nervous | 2.03849797 |
| 18 | MP0005257_abnormal_intraocular_pressure | 1.96397697 |
| 19 | MP0005058_abnormal_lysosome_morphology | 1.93660798 |
| 20 | MP0003718_maternal_effect | 1.92120972 |
| 21 | MP0002876_abnormal_thyroid_physiology | 1.91956896 |
| 22 | MP0002272_abnormal_nervous_system | 1.90480815 |
| 23 | MP0002736_abnormal_nociception_after | 1.88221472 |
| 24 | MP0003566_abnormal_cell_adhesion | 1.85931225 |
| 25 | MP0005646_abnormal_pituitary_gland | 1.84017725 |
| 26 | MP0002064_seizures | 1.80207220 |
| 27 | MP0004270_analgesia | 1.78780580 |
| 28 | MP0005165_increased_susceptibility_to | 1.76067575 |
| 29 | MP0003806_abnormal_nucleotide_metabolis | 1.76055829 |
| 30 | MP0001188_hyperpigmentation | 1.75441929 |
| 31 | MP0003690_abnormal_glial_cell | 1.70569247 |
| 32 | MP0004142_abnormal_muscle_tone | 1.69503411 |
| 33 | MP0000358_abnormal_cell_content/ | 1.68685788 |
| 34 | MP0003950_abnormal_plasma_membrane | 1.64911282 |
| 35 | MP0009745_abnormal_behavioral_response | 1.63199538 |
| 36 | MP0004147_increased_porphyrin_level | 1.59780667 |
| 37 | MP0003279_aneurysm | 1.58152795 |
| 38 | MP0010368_abnormal_lymphatic_system | 1.57421209 |
| 39 | MP0004742_abnormal_vestibular_system | 1.56991799 |
| 40 | MP0005451_abnormal_body_composition | 1.56391646 |
| 41 | MP0005084_abnormal_gallbladder_morpholo | 1.55846023 |
| 42 | MP0001986_abnormal_taste_sensitivity | 1.55567687 |
| 43 | MP0002735_abnormal_chemical_nociception | 1.53589032 |
| 44 | MP0002734_abnormal_mechanical_nocicepti | 1.51036242 |
| 45 | MP0002148_abnormal_hypersensitivity_rea | 1.50848208 |
| 46 | MP0009764_decreased_sensitivity_to | 1.48532058 |
| 47 | MP0001968_abnormal_touch/_nociception | 1.46474838 |
| 48 | MP0003183_abnormal_peptide_metabolism | 1.46207966 |
| 49 | MP0005645_abnormal_hypothalamus_physiol | 1.46166072 |
| 50 | MP0003186_abnormal_redox_activity | 1.45159387 |
| 51 | MP0003448_altered_tumor_morphology | 1.45080399 |
| 52 | MP0006035_abnormal_mitochondrial_morpho | 1.43569502 |
| 53 | MP0002139_abnormal_hepatobiliary_system | 1.43226726 |
| 54 | MP0008875_abnormal_xenobiotic_pharmacok | 1.43197290 |
| 55 | MP0005275_abnormal_skin_tensile | 1.42326652 |
| 56 | MP0001243_abnormal_dermal_layer | 1.41903010 |
| 57 | MP0002877_abnormal_melanocyte_morpholog | 1.39607360 |
| 58 | MP0000778_abnormal_nervous_system | 1.39214403 |
| 59 | MP0005167_abnormal_blood-brain_barrier | 1.37557468 |
| 60 | MP0009046_muscle_twitch | 1.36693434 |
| 61 | MP0000013_abnormal_adipose_tissue | 1.35579300 |
| 62 | MP0003724_increased_susceptibility_to | 1.32952825 |
| 63 | MP0002572_abnormal_emotion/affect_behav | 1.32332026 |
| 64 | MP0005623_abnormal_meninges_morphology | 1.31366870 |
| 65 | MP0008007_abnormal_cellular_replicative | 1.31046405 |
| 66 | MP0002638_abnormal_pupillary_reflex | 1.30382854 |
| 67 | MP0005409_darkened_coat_color | 1.29987740 |
| 68 | MP0002102_abnormal_ear_morphology | 1.29705228 |
| 69 | MP0002837_dystrophic_cardiac_calcinosis | 1.29567338 |
| 70 | MP0009384_cardiac_valve_regurgitation | 1.29096524 |
| 71 | MP0001984_abnormal_olfaction | 1.27881266 |
| 72 | MP0003634_abnormal_glial_cell | 1.27707179 |
| 73 | MP0003329_amyloid_beta_deposits | 1.27474590 |
| 74 | MP0003635_abnormal_synaptic_transmissio | 1.26937814 |
| 75 | MP0001501_abnormal_sleep_pattern | 1.26083573 |
| 76 | MP0000372_irregular_coat_pigmentation | 1.25863106 |
| 77 | MP0001486_abnormal_startle_reflex | 1.23868161 |
| 78 | MP0005408_hypopigmentation | 1.21277646 |
| 79 | MP0005023_abnormal_wound_healing | 1.21003606 |
| 80 | MP0001970_abnormal_pain_threshold | 1.20463626 |
| 81 | MP0003011_delayed_dark_adaptation | 1.19740282 |
| 82 | MP0008932_abnormal_embryonic_tissue | 1.18787108 |
| 83 | MP0000538_abnormal_urinary_bladder | 1.16252356 |
| 84 | MP0000516_abnormal_urinary_system | 1.15486007 |
| 85 | MP0005367_renal/urinary_system_phenotyp | 1.15486007 |
| 86 | MP0001502_abnormal_circadian_rhythm | 1.13700105 |
| 87 | MP0000647_abnormal_sebaceous_gland | 1.13528061 |
| 88 | MP0002067_abnormal_sensory_capabilities | 1.12676115 |
| 89 | MP0004510_myositis | 1.12577840 |
| 90 | MP0002295_abnormal_pulmonary_circulatio | 1.12045012 |
| 91 | MP0002063_abnormal_learning/memory/cond | 1.11728777 |
| 92 | MP0005360_urolithiasis | 1.10320843 |
| 93 | MP0009697_abnormal_copulation | 1.10252745 |
| 94 | MP0003136_yellow_coat_color | 1.09735492 |
| 95 | MP0005551_abnormal_eye_electrophysiolog | 1.09731620 |
| 96 | MP0003122_maternal_imprinting | 1.09390754 |
| 97 | MP0005332_abnormal_amino_acid | 1.09287778 |
| 98 | MP0005410_abnormal_fertilization | 1.09237139 |
| 99 | MP0002733_abnormal_thermal_nociception | 1.09166751 |
| 100 | MP0002229_neurodegeneration | 1.08929576 |
| 101 | MP0001879_abnormal_lymphatic_vessel | 1.07363328 |
| 102 | MP0005423_abnormal_somatic_nervous | 1.06908340 |
| 103 | MP0005503_abnormal_tendon_morphology | 1.05973183 |
| 104 | MP0003075_altered_response_to | 1.05950727 |
| 105 | MP0002090_abnormal_vision | 1.05764381 |
| 106 | MP0005379_endocrine/exocrine_gland_phen | 1.03953548 |
| 107 | MP0005164_abnormal_response_to | 1.03730496 |
| 108 | MP0005508_abnormal_skeleton_morphology | 1.01662453 |
| 109 | MP0005636_abnormal_mineral_homeostasis | 1.00940826 |
| 110 | MP0006082_CNS_inflammation | 1.00148401 |
| 111 | MP0004134_abnormal_chest_morphology | 0.99962468 |
| 112 | MP0001764_abnormal_homeostasis | 0.99903411 |
| 113 | MP0009780_abnormal_chondrocyte_physiolo | 0.96854850 |
| 114 | MP0006036_abnormal_mitochondrial_physio | 0.95989326 |
| 115 | MP0001849_ear_inflammation | 0.93857501 |
| 116 | MP0008058_abnormal_DNA_repair | 0.93375073 |
| 117 | MP0001440_abnormal_grooming_behavior | 0.93180519 |
| 118 | MP0004883_abnormal_blood_vessel | 0.92968451 |
| 119 | MP0010030_abnormal_orbit_morphology | 0.92456843 |
| 120 | MP0000230_abnormal_systemic_arterial | 0.91470427 |
| 121 | MP0001963_abnormal_hearing_physiology | 0.90836447 |
| 122 | MP0005535_abnormal_body_temperature | 0.90149021 |
| 123 | MP0009765_abnormal_xenobiotic_induced | 0.89467980 |
| 124 | MP0000681_abnormal_thyroid_gland | 0.89084507 |
| 125 | MP0003638_abnormal_response/metabolism_ | 0.88509978 |
| 126 | MP0002557_abnormal_social/conspecific_i | 0.88313474 |
| 127 | MP0001664_abnormal_digestion | 0.87749742 |
| 128 | MP0008260_abnormal_autophagy | 0.87194204 |
| 129 | MP0005365_abnormal_bile_salt | 0.87091659 |
| 130 | MP0001853_heart_inflammation | 0.85944166 |
| 131 | MP0000631_abnormal_neuroendocrine_gland | 0.85482178 |
| 132 | MP0002998_abnormal_bone_remodeling | 0.84111404 |
| 133 | MP0004957_abnormal_blastocyst_morpholog | 0.83824082 |
| 134 | MP0001542_abnormal_bone_strength | 0.83814875 |
| 135 | MP0002066_abnormal_motor_capabilities/c | 0.82874128 |
| 136 | MP0001727_abnormal_embryo_implantation | 0.82372159 |
| 137 | MP0006072_abnormal_retinal_apoptosis | 0.81992498 |
| 138 | MP0000026_abnormal_inner_ear | 0.81725510 |
| 139 | MP0005193_abnormal_anterior_eye | 0.81626143 |
| 140 | MP0003795_abnormal_bone_structure | 0.81195350 |
| 141 | MP0009053_abnormal_anal_canal | 0.81013825 |
| 142 | MP0000015_abnormal_ear_pigmentation | 0.80495551 |
| 143 | MP0003693_abnormal_embryo_hatching | 0.80129740 |
| 144 | MP0008438_abnormal_cutaneous_collagen | 0.80036347 |
| 145 | MP0000604_amyloidosis | 0.79751762 |
| 146 | MP0002896_abnormal_bone_mineralization | 0.79573575 |
| 147 | MP0000858_altered_metastatic_potential | 0.78802855 |
| 148 | MP0002282_abnormal_trachea_morphology | 0.78199848 |
| 149 | MP0008004_abnormal_stomach_pH | 0.78040664 |
| 150 | MP0001299_abnormal_eye_distance/ | 0.77468513 |
| 151 | MP0008873_increased_physiological_sensi | 0.77467994 |
| 152 | MP0009763_increased_sensitivity_to | 0.76378834 |
| 153 | MP0005197_abnormal_uvea_morphology | 0.76180189 |
| 154 | MP0001756_abnormal_urination | 0.75460603 |
| 155 | MP0005595_abnormal_vascular_smooth | 0.75238499 |
| 156 | MP0003191_abnormal_cellular_cholesterol | 0.74723426 |
| 157 | MP0004885_abnormal_endolymph | 0.74436463 |
| 158 | MP0010771_integument_phenotype | 0.73611664 |
| 159 | MP0000462_abnormal_digestive_system | 0.73549976 |
| 160 | MP0004924_abnormal_behavior | 0.73471730 |
| 161 | MP0005386_behavior/neurological_phenoty | 0.73471730 |
| 162 | MP0001533_abnormal_skeleton_physiology | 0.72576645 |
| 163 | MP0005501_abnormal_skin_physiology | 0.70713117 |
| 164 | MP0001191_abnormal_skin_condition | 0.67952567 |
| 165 | MP0005390_skeleton_phenotype | 0.66249835 |
| 166 | MP0002060_abnormal_skin_morphology | 0.63496988 |
| 167 | MP0010352_gastrointestinal_tract_polyps | 0.59912748 |
| 168 | MP0000537_abnormal_urethra_morphology | 0.57878195 |
| 169 | MP0002972_abnormal_cardiac_muscle | 0.57453143 |
| 170 | MP0005384_cellular_phenotype | 0.57115063 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 5.35553613 |
| 2 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.89814987 |
| 3 | Acute encephalopathy (HP:0006846) | 4.64461483 |
| 4 | Mitochondrial inheritance (HP:0001427) | 4.61888095 |
| 5 | Progressive macrocephaly (HP:0004481) | 4.33052875 |
| 6 | Hepatocellular necrosis (HP:0001404) | 4.08171132 |
| 7 | Petechiae (HP:0000967) | 3.88560360 |
| 8 | Abnormality of glycolipid metabolism (HP:0010969) | 3.77996622 |
| 9 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.77996622 |
| 10 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.77996622 |
| 11 | Increased CSF lactate (HP:0002490) | 3.75615487 |
| 12 | Hepatic necrosis (HP:0002605) | 3.61139766 |
| 13 | Renal Fanconi syndrome (HP:0001994) | 3.50480046 |
| 14 | 3-Methylglutaconic aciduria (HP:0003535) | 3.50203282 |
| 15 | Abnormality of glycolysis (HP:0004366) | 3.45126038 |
| 16 | Increased serum pyruvate (HP:0003542) | 3.45126038 |
| 17 | Premature rupture of membranes (HP:0001788) | 3.41268012 |
| 18 | Purpura (HP:0000979) | 3.19247045 |
| 19 | Increased hepatocellular lipid droplets (HP:0006565) | 3.16839791 |
| 20 | Neuroendocrine neoplasm (HP:0100634) | 3.14170218 |
| 21 | Leukodystrophy (HP:0002415) | 3.13600638 |
| 22 | Tetraparesis (HP:0002273) | 3.13007478 |
| 23 | Cerebral edema (HP:0002181) | 3.08551215 |
| 24 | Menorrhagia (HP:0000132) | 3.06127413 |
| 25 | Increased mean platelet volume (HP:0011877) | 3.05445069 |
| 26 | Pheochromocytoma (HP:0002666) | 3.03759847 |
| 27 | Lipid accumulation in hepatocytes (HP:0006561) | 2.98947352 |
| 28 | Neurofibrillary tangles (HP:0002185) | 2.87228181 |
| 29 | Nausea (HP:0002018) | 2.84943273 |
| 30 | Hypothermia (HP:0002045) | 2.82995625 |
| 31 | Disinhibition (HP:0000734) | 2.81047154 |
| 32 | Retinal dysplasia (HP:0007973) | 2.80310059 |
| 33 | Mutism (HP:0002300) | 2.77475203 |
| 34 | Respiratory failure (HP:0002878) | 2.75230446 |
| 35 | Lactic acidosis (HP:0003128) | 2.74561386 |
| 36 | Optic disc pallor (HP:0000543) | 2.72765988 |
| 37 | Abnormality of renal resorption (HP:0011038) | 2.72297267 |
| 38 | Systemic lupus erythematosus (HP:0002725) | 2.70786871 |
| 39 | Increased intramyocellular lipid droplets (HP:0012240) | 2.68448330 |
| 40 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.63312851 |
| 41 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.59838389 |
| 42 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.59166621 |
| 43 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.59154937 |
| 44 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.57683795 |
| 45 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.55449238 |
| 46 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.54722073 |
| 47 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.54327709 |
| 48 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.54327709 |
| 49 | Sensory axonal neuropathy (HP:0003390) | 2.51525697 |
| 50 | Vacuolated lymphocytes (HP:0001922) | 2.49344347 |
| 51 | Loss of speech (HP:0002371) | 2.49305437 |
| 52 | Reduced antithrombin III activity (HP:0001976) | 2.47343331 |
| 53 | Exercise intolerance (HP:0003546) | 2.46933644 |
| 54 | Agnosia (HP:0010524) | 2.45446205 |
| 55 | Abnormal platelet volume (HP:0011876) | 2.44062953 |
| 56 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.43665989 |
| 57 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.43665989 |
| 58 | Abnormal protein glycosylation (HP:0012346) | 2.40780140 |
| 59 | Abnormal glycosylation (HP:0012345) | 2.40780140 |
| 60 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.40780140 |
| 61 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.40780140 |
| 62 | Nuclear cataract (HP:0100018) | 2.39739690 |
| 63 | Increased muscle lipid content (HP:0009058) | 2.38825871 |
| 64 | Medial flaring of the eyebrow (HP:0010747) | 2.38114939 |
| 65 | Sensorimotor neuropathy (HP:0007141) | 2.37924470 |
| 66 | Metaphyseal dysplasia (HP:0100255) | 2.35852479 |
| 67 | Increased serum lactate (HP:0002151) | 2.34871228 |
| 68 | Abnormality of urine glucose concentration (HP:0011016) | 2.33723747 |
| 69 | Glycosuria (HP:0003076) | 2.33723747 |
| 70 | Conjunctival telangiectasia (HP:0000524) | 2.30509432 |
| 71 | Prolonged partial thromboplastin time (HP:0003645) | 2.28368847 |
| 72 | Hypomagnesemia (HP:0002917) | 2.28287808 |
| 73 | Abnormality of methionine metabolism (HP:0010901) | 2.28230863 |
| 74 | Parakeratosis (HP:0001036) | 2.26975267 |
| 75 | Type II lissencephaly (HP:0007260) | 2.26904613 |
| 76 | Short middle phalanx of the 5th finger (HP:0004220) | 2.26717382 |
| 77 | Abnormal hair whorl (HP:0010721) | 2.25871124 |
| 78 | Methylmalonic acidemia (HP:0002912) | 2.25082663 |
| 79 | Methylmalonic aciduria (HP:0012120) | 2.24932193 |
| 80 | Cerebral hemorrhage (HP:0001342) | 2.23431643 |
| 81 | Intrahepatic cholestasis (HP:0001406) | 2.22012279 |
| 82 | Increased cerebral lipofuscin (HP:0011813) | 2.21384900 |
| 83 | Basal ganglia calcification (HP:0002135) | 2.21367481 |
| 84 | Abnormality of alanine metabolism (HP:0010916) | 2.18060099 |
| 85 | Hyperalaninemia (HP:0003348) | 2.18060099 |
| 86 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.18060099 |
| 87 | Abnormality of magnesium homeostasis (HP:0004921) | 2.17696194 |
| 88 | Postnatal microcephaly (HP:0005484) | 2.13600002 |
| 89 | Myokymia (HP:0002411) | 2.12816733 |
| 90 | Abnormality of the basal ganglia (HP:0002134) | 2.10824954 |
| 91 | Poor suck (HP:0002033) | 2.09729552 |
| 92 | Renal tubular dysfunction (HP:0000124) | 2.09406787 |
| 93 | Degeneration of anterior horn cells (HP:0002398) | 2.06860683 |
| 94 | Abnormality of the anterior horn cell (HP:0006802) | 2.06860683 |
| 95 | Hyperventilation (HP:0002883) | 2.05819390 |
| 96 | Sparse eyelashes (HP:0000653) | 2.05602636 |
| 97 | Upper limb muscle weakness (HP:0003484) | 2.04826173 |
| 98 | Rough bone trabeculation (HP:0100670) | 2.04656229 |
| 99 | Generalized aminoaciduria (HP:0002909) | 2.04555348 |
| 100 | Spastic paraparesis (HP:0002313) | 2.03101774 |
| 101 | Nephrogenic diabetes insipidus (HP:0009806) | 2.02102568 |
| 102 | Gait imbalance (HP:0002141) | 2.01098693 |
| 103 | Vascular calcification (HP:0004934) | 2.00436580 |
| 104 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.00410571 |
| 105 | Follicular hyperkeratosis (HP:0007502) | 1.99966393 |
| 106 | Cardiovascular calcification (HP:0011915) | 1.99419283 |
| 107 | Poor head control (HP:0002421) | 1.98723487 |
| 108 | Vaginal atresia (HP:0000148) | 1.97215196 |
| 109 | Congenital primary aphakia (HP:0007707) | 1.95432141 |
| 110 | Delusions (HP:0000746) | 1.94994577 |
| 111 | Polyphagia (HP:0002591) | 1.94724651 |
| 112 | Prolonged bleeding time (HP:0003010) | 1.94056600 |
| 113 | Exertional dyspnea (HP:0002875) | 1.93431738 |
| 114 | X-linked dominant inheritance (HP:0001423) | 1.89817726 |
| 115 | Abnormal trabecular bone morphology (HP:0100671) | 1.89648461 |
| 116 | Metabolic alkalosis (HP:0200114) | 1.89415832 |
| 117 | Patchy hypopigmentation of hair (HP:0011365) | 1.88853201 |
| 118 | Genital tract atresia (HP:0001827) | 1.88598462 |
| 119 | Beaking of vertebral bodies (HP:0004568) | 1.88039560 |
| 120 | Dry hair (HP:0011359) | 1.88032680 |
| 121 | Paralysis (HP:0003470) | 1.87536362 |
| 122 | Hypophosphatemic rickets (HP:0004912) | 1.86512464 |
| 123 | Congenital, generalized hypertrichosis (HP:0004540) | 1.85557570 |
| 124 | Lethargy (HP:0001254) | 1.85067866 |
| 125 | Abnormality of serum amino acid levels (HP:0003112) | 1.84215472 |
| 126 | Autoamputation (HP:0001218) | 1.83890768 |
| 127 | Limb dystonia (HP:0002451) | 1.83274005 |
| 128 | Prolonged neonatal jaundice (HP:0006579) | 1.81967238 |
| 129 | Hepatosplenomegaly (HP:0001433) | 1.81949367 |
| 130 | Bifid tongue (HP:0010297) | 1.80022564 |
| 131 | Irregular vertebral endplates (HP:0003301) | 1.78974057 |
| 132 | Abnormal pupillary function (HP:0007686) | 1.78753170 |
| 133 | CNS demyelination (HP:0007305) | 1.78719398 |
| 134 | Abnormal platelet function (HP:0011869) | 1.78492384 |
| 135 | Impaired platelet aggregation (HP:0003540) | 1.78492384 |
| 136 | Hyperphosphaturia (HP:0003109) | 1.78368179 |
| 137 | Vertebral compression fractures (HP:0002953) | 1.77244853 |
| 138 | Progressive neurologic deterioration (HP:0002344) | 1.76670916 |
| 139 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.76417805 |
| 140 | Cerebral hypomyelination (HP:0006808) | 1.76190279 |
| 141 | Hyperglycinemia (HP:0002154) | 1.75755890 |
| 142 | Focal motor seizures (HP:0011153) | 1.75313691 |
| 143 | Delayed gross motor development (HP:0002194) | 1.75060568 |
| 144 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 1.75011972 |
| 145 | Fasciculations (HP:0002380) | 1.73759855 |
| 146 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.73715923 |
| 147 | Absent/shortened dynein arms (HP:0200106) | 1.73715923 |
| 148 | Opisthotonus (HP:0002179) | 1.72951472 |
| 149 | Poor speech (HP:0002465) | 1.72631606 |
| 150 | Type I transferrin isoform profile (HP:0003642) | 1.71072455 |
| 151 | Hypokalemic alkalosis (HP:0001949) | 1.70796197 |
| 152 | White forelock (HP:0002211) | 1.69822923 |
| 153 | Dysostosis multiplex (HP:0000943) | 1.69608155 |
| 154 | Conjugated hyperbilirubinemia (HP:0002908) | 1.69341506 |
| 155 | Thyroid-stimulating hormone excess (HP:0002925) | 1.68396259 |
| 156 | Atonic seizures (HP:0010819) | 1.67420049 |
| 157 | Vomiting (HP:0002013) | 1.66865484 |
| 158 | Lissencephaly (HP:0001339) | 1.65321993 |
| 159 | Abnormal ciliary motility (HP:0012262) | 1.64609422 |
| 160 | Increased circulating renin level (HP:0000848) | 1.64031154 |
| 161 | Thickened helices (HP:0000391) | 1.63579954 |
| 162 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.61709360 |
| 163 | Dicarboxylic aciduria (HP:0003215) | 1.61709360 |
| 164 | Respiratory difficulties (HP:0002880) | 1.59091958 |
| 165 | Cerebral inclusion bodies (HP:0100314) | 1.57069855 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 3.61186331 |
| 2 | OXSR1 | 3.29455540 |
| 3 | NME2 | 3.14880873 |
| 4 | STK39 | 3.14503314 |
| 5 | STK16 | 2.93030873 |
| 6 | TRIM28 | 2.69200428 |
| 7 | BCR | 2.28718634 |
| 8 | MAP3K12 | 2.26869798 |
| 9 | CDK19 | 2.26667095 |
| 10 | BMPR1B | 1.99269290 |
| 11 | PRPF4B | 1.93018882 |
| 12 | BUB1 | 1.92375718 |
| 13 | WNK4 | 1.86551241 |
| 14 | MST4 | 1.80954458 |
| 15 | TNIK | 1.80469358 |
| 16 | ARAF | 1.78808076 |
| 17 | GRK7 | 1.70710669 |
| 18 | LIMK1 | 1.70363276 |
| 19 | TSSK6 | 1.63924002 |
| 20 | ADRBK2 | 1.63755469 |
| 21 | WNK3 | 1.63633231 |
| 22 | PBK | 1.62530052 |
| 23 | MYLK | 1.59826957 |
| 24 | SRPK1 | 1.59648543 |
| 25 | EIF2AK1 | 1.55696812 |
| 26 | MAPK13 | 1.53051238 |
| 27 | DYRK2 | 1.46842987 |
| 28 | MAPK15 | 1.45987750 |
| 29 | NEK1 | 1.45702081 |
| 30 | CSNK1G3 | 1.45080341 |
| 31 | BCKDK | 1.42590376 |
| 32 | MAPKAPK5 | 1.42110164 |
| 33 | SCYL2 | 1.40523592 |
| 34 | NME1 | 1.37436394 |
| 35 | MAP4K2 | 1.37274306 |
| 36 | ACVR1B | 1.36951691 |
| 37 | BMX | 1.35464336 |
| 38 | TAOK2 | 1.33615778 |
| 39 | EIF2AK3 | 1.32802549 |
| 40 | PLK3 | 1.32660469 |
| 41 | MAP2K7 | 1.27254842 |
| 42 | SIK3 | 1.26479765 |
| 43 | MARK1 | 1.20075047 |
| 44 | FER | 1.19830459 |
| 45 | PAK4 | 1.19437176 |
| 46 | TGFBR2 | 1.19341344 |
| 47 | PKN1 | 1.18352375 |
| 48 | DDR2 | 1.18054064 |
| 49 | CAMK2B | 1.17740337 |
| 50 | BMPR2 | 1.16881308 |
| 51 | VRK2 | 1.16291930 |
| 52 | NEK6 | 1.15177154 |
| 53 | VRK1 | 1.14455012 |
| 54 | BRAF | 1.13834782 |
| 55 | MET | 1.13739954 |
| 56 | TAOK3 | 1.10771613 |
| 57 | SGK494 | 1.09729743 |
| 58 | SGK223 | 1.09729743 |
| 59 | PNCK | 1.08829561 |
| 60 | CSNK1G1 | 1.06365114 |
| 61 | TIE1 | 1.02659911 |
| 62 | IRAK3 | 1.02263132 |
| 63 | CSNK1A1L | 1.02079460 |
| 64 | PIK3CG | 0.98571328 |
| 65 | NUAK1 | 0.96108745 |
| 66 | GRK5 | 0.95371323 |
| 67 | CSNK1G2 | 0.93738939 |
| 68 | EPHB2 | 0.93413626 |
| 69 | PRKCE | 0.93365303 |
| 70 | AKT3 | 0.91192504 |
| 71 | MKNK1 | 0.91138333 |
| 72 | MAP3K5 | 0.90445812 |
| 73 | EPHA4 | 0.89831421 |
| 74 | CAMK2G | 0.89492006 |
| 75 | IRAK4 | 0.88952498 |
| 76 | MUSK | 0.88792341 |
| 77 | UHMK1 | 0.87187098 |
| 78 | PTK2B | 0.85693087 |
| 79 | CAMK2D | 0.85128924 |
| 80 | INSRR | 0.83028536 |
| 81 | YES1 | 0.82876014 |
| 82 | RPS6KA4 | 0.82127023 |
| 83 | CAMK2A | 0.81100611 |
| 84 | TTK | 0.80988608 |
| 85 | PIM2 | 0.79689093 |
| 86 | STK3 | 0.77510947 |
| 87 | PAK1 | 0.75131543 |
| 88 | FGR | 0.74050244 |
| 89 | MKNK2 | 0.73224237 |
| 90 | IRAK1 | 0.72429522 |
| 91 | ROCK2 | 0.72273791 |
| 92 | MATK | 0.72241182 |
| 93 | PRKCG | 0.71526450 |
| 94 | EPHB1 | 0.70767617 |
| 95 | PLK1 | 0.68833009 |
| 96 | LATS2 | 0.68243889 |
| 97 | PLK2 | 0.64667063 |
| 98 | FGFR2 | 0.64259347 |
| 99 | DAPK1 | 0.63957790 |
| 100 | CDK5 | 0.62899583 |
| 101 | GRK1 | 0.60983902 |
| 102 | ADRBK1 | 0.60496516 |
| 103 | CCNB1 | 0.60347550 |
| 104 | TESK1 | 0.59681406 |
| 105 | CDC7 | 0.59355312 |
| 106 | TRPM7 | 0.58662394 |
| 107 | MAP2K2 | 0.58119230 |
| 108 | PTK2 | 0.57467662 |
| 109 | DYRK3 | 0.57166611 |
| 110 | ABL2 | 0.56984528 |
| 111 | MAP3K3 | 0.56343561 |
| 112 | ERBB4 | 0.56205216 |
| 113 | PAK2 | 0.55222685 |
| 114 | CDK8 | 0.54774103 |
| 115 | TGFBR1 | 0.54662249 |
| 116 | DAPK3 | 0.54386776 |
| 117 | PRKG2 | 0.54214414 |
| 118 | FLT3 | 0.54036996 |
| 119 | CSF1R | 0.53647064 |
| 120 | CDK14 | 0.52049414 |
| 121 | ZAK | 0.51460240 |
| 122 | CDK18 | 0.51114848 |
| 123 | AURKA | 0.51001554 |
| 124 | DAPK2 | 0.50085366 |
| 125 | IRAK2 | 0.48412330 |
| 126 | OBSCN | 0.47881931 |
| 127 | FES | 0.46815904 |
| 128 | KDR | 0.46089782 |
| 129 | MINK1 | 0.45105200 |
| 130 | ERBB3 | 0.45055566 |
| 131 | CSNK2A1 | 0.44834162 |
| 132 | CDK15 | 0.43556122 |
| 133 | TLK1 | 0.43411114 |
| 134 | PAK3 | 0.43316831 |
| 135 | MOS | 0.42889120 |
| 136 | NTRK1 | 0.42835074 |
| 137 | CSNK1A1 | 0.42542476 |
| 138 | GSK3A | 0.42479361 |
| 139 | FGFR1 | 0.42328939 |
| 140 | STK4 | 0.42324289 |
| 141 | PRKACA | 0.41991539 |
| 142 | MAP3K14 | 0.41989200 |
| 143 | KIT | 0.41829983 |
| 144 | WEE1 | 0.41496198 |
| 145 | PRKCD | 0.40718555 |
| 146 | CDK11A | 0.40686367 |
| 147 | MAP3K11 | 0.39625397 |
| 148 | PDK2 | 0.39005003 |
| 149 | NTRK3 | 0.37510302 |
| 150 | EPHA3 | 0.37492497 |
| 151 | TESK2 | 0.37052251 |
| 152 | PRKG1 | 0.35530224 |
| 153 | ILK | 0.35264269 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.67171681 |
| 2 | Protein export_Homo sapiens_hsa03060 | 3.74932614 |
| 3 | Parkinsons disease_Homo sapiens_hsa05012 | 3.52391737 |
| 4 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.90814655 |
| 5 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.88413399 |
| 6 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.77816232 |
| 7 | Alzheimers disease_Homo sapiens_hsa05010 | 2.76442166 |
| 8 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.63031140 |
| 9 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.35339444 |
| 10 | Huntingtons disease_Homo sapiens_hsa05016 | 2.26526264 |
| 11 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.26523165 |
| 12 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.25163448 |
| 13 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.06099293 |
| 14 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.93768575 |
| 15 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.90060977 |
| 16 | Proteasome_Homo sapiens_hsa03050 | 1.82792634 |
| 17 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.68425097 |
| 18 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.65737716 |
| 19 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.61598155 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.59976630 |
| 21 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.59393839 |
| 22 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.53301291 |
| 23 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.41427822 |
| 24 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.38998355 |
| 25 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.38914303 |
| 26 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.38592966 |
| 27 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.33060097 |
| 28 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.32611428 |
| 29 | Mismatch repair_Homo sapiens_hsa03430 | 1.30783712 |
| 30 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.29316018 |
| 31 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.29025535 |
| 32 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.26242358 |
| 33 | Peroxisome_Homo sapiens_hsa04146 | 1.25861688 |
| 34 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.25092176 |
| 35 | Phagosome_Homo sapiens_hsa04145 | 1.21410159 |
| 36 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.18190893 |
| 37 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.17856398 |
| 38 | Shigellosis_Homo sapiens_hsa05131 | 1.16841136 |
| 39 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.10796861 |
| 40 | Lysosome_Homo sapiens_hsa04142 | 1.10316533 |
| 41 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.09541664 |
| 42 | Basal transcription factors_Homo sapiens_hsa03022 | 1.09062054 |
| 43 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.08753467 |
| 44 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.08610144 |
| 45 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.07660102 |
| 46 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.06934622 |
| 47 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.05609748 |
| 48 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.03299842 |
| 49 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.00762557 |
| 50 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.98372679 |
| 51 | Nicotine addiction_Homo sapiens_hsa05033 | 0.93661173 |
| 52 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.92951694 |
| 53 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.91290182 |
| 54 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.88903573 |
| 55 | Metabolic pathways_Homo sapiens_hsa01100 | 0.88440371 |
| 56 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.87404873 |
| 57 | Salmonella infection_Homo sapiens_hsa05132 | 0.85253788 |
| 58 | GABAergic synapse_Homo sapiens_hsa04727 | 0.85191865 |
| 59 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.84272834 |
| 60 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.83377283 |
| 61 | Other glycan degradation_Homo sapiens_hsa00511 | 0.82430318 |
| 62 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.80775450 |
| 63 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.80170330 |
| 64 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.80021676 |
| 65 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.80014266 |
| 66 | RNA polymerase_Homo sapiens_hsa03020 | 0.79951890 |
| 67 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.79355278 |
| 68 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.77111536 |
| 69 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.76968043 |
| 70 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.76843977 |
| 71 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.76343745 |
| 72 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.75782549 |
| 73 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.73484863 |
| 74 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.71974231 |
| 75 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.70754768 |
| 76 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.70205168 |
| 77 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.67097866 |
| 78 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.65372624 |
| 79 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.64649728 |
| 80 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.63929759 |
| 81 | Legionellosis_Homo sapiens_hsa05134 | 0.62442159 |
| 82 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.60649422 |
| 83 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.59961685 |
| 84 | Morphine addiction_Homo sapiens_hsa05032 | 0.58826887 |
| 85 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.58249048 |
| 86 | Galactose metabolism_Homo sapiens_hsa00052 | 0.58223328 |
| 87 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.56316277 |
| 88 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.56176637 |
| 89 | Phototransduction_Homo sapiens_hsa04744 | 0.54612462 |
| 90 | Sulfur relay system_Homo sapiens_hsa04122 | 0.53371840 |
| 91 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.52574340 |
| 92 | Cocaine addiction_Homo sapiens_hsa05030 | 0.50715218 |
| 93 | Base excision repair_Homo sapiens_hsa03410 | 0.50185192 |
| 94 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.49370696 |
| 95 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.48641402 |
| 96 | Retinol metabolism_Homo sapiens_hsa00830 | 0.48264611 |
| 97 | RNA transport_Homo sapiens_hsa03013 | 0.48234346 |
| 98 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.47418739 |
| 99 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.47238203 |
| 100 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.46247038 |
| 101 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.45485676 |
| 102 | Taste transduction_Homo sapiens_hsa04742 | 0.44895613 |
| 103 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.44794818 |
| 104 | Axon guidance_Homo sapiens_hsa04360 | 0.43617247 |
| 105 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.43380545 |
| 106 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.43340907 |
| 107 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.41961180 |
| 108 | Circadian entrainment_Homo sapiens_hsa04713 | 0.41038729 |
| 109 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.40833674 |
| 110 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.40415328 |
| 111 | RNA degradation_Homo sapiens_hsa03018 | 0.40331241 |
| 112 | Mineral absorption_Homo sapiens_hsa04978 | 0.39664809 |
| 113 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.39197643 |
| 114 | Endocytosis_Homo sapiens_hsa04144 | 0.38984631 |
| 115 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.38815976 |
| 116 | Malaria_Homo sapiens_hsa05144 | 0.36460601 |
| 117 | DNA replication_Homo sapiens_hsa03030 | 0.36041724 |
| 118 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.35944466 |
| 119 | Spliceosome_Homo sapiens_hsa03040 | 0.32516884 |
| 120 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.32178359 |
| 121 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.30669396 |
| 122 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.28727684 |
| 123 | Purine metabolism_Homo sapiens_hsa00230 | 0.28512195 |
| 124 | Insulin secretion_Homo sapiens_hsa04911 | 0.28209807 |
| 125 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.28108535 |
| 126 | Ribosome_Homo sapiens_hsa03010 | 0.26868615 |
| 127 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.25355155 |
| 128 | Carbon metabolism_Homo sapiens_hsa01200 | 0.24934877 |
| 129 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.24000405 |
| 130 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.22931655 |
| 131 | Asthma_Homo sapiens_hsa05310 | 0.22806796 |
| 132 | Pertussis_Homo sapiens_hsa05133 | 0.21639977 |
| 133 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.20587598 |
| 134 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.20205266 |

